Form 4 for TWST Twist Bioscience Corp

Accepted 2023-11-06 00:00:00 ET · period of report 2023-11-02 · accession 0001214659-23-014605 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-11-06	2023-11-02	TWST	Finn Patrick John	Pres, COO	A - Grant	$0.00	+99.5K	184.6K	+117%	$0
	2023-11-06	2023-11-02	TWST	Finn Patrick John	Pres, COO	F - Tax	$17.31	-4,158	104.8K	-4%	-$72.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-11-02	A	A	19,743	$0.00	108,932	D	—	—	(F1) Represents performance stock units for which target criteria was determined to have been met on November 2, 2023. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2024, subject to continued service or acceleration of vesting as provided in the award agreement.
2	Common	Common Stock	2023-11-02	F	D	4,158	$17.31	104,774	D	—	—	(F2) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
3	Common	Common Stock	2023-11-02	A	A	79,785	$0.00	184,559	D	—	—	(F3) Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 2, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.